# Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

> **NCT07427680** · PHASE1,PHASE2 · RECRUITING · sponsor: **Tangram Therapeutics Plc** · enrollment: 99 (estimated)

## Conditions studied

- Healthy Participants
- MASH - Metabolic Dysfunction-Associated Steatohepatitis

## Interventions

- **DRUG:** TGM-312-SC01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07427680
- **Lead sponsor:** Tangram Therapeutics Plc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2028-03
- **Final completion:** 2028-06
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07427680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07427680, "Study of TGM-312-SC01 in Healthy Participants and Adults With MASH". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07427680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*